Table 3.
Parameter | Estimate (SE) | Z | Pr > Z | Hazard ratio (95% CI) |
---|---|---|---|---|
Age group (years) | ||||
≤ 60 | − 0.11 (0.43) | − 0.25 | 0.80 | 0.90 (0.39–2.08) |
61–70 | − 0.21 (0.42) | − 0.51 | 0.61 | 0.81 (0.36–1.84) |
> 70 | Reference | |||
Gender | ||||
Male | − 0.61 (0.18) | − 3.45 | < 0.001 | 0.54 (0.39–0.77) |
Female | Reference | |||
CCI | − 0.12 (0.07) | − 1.60 | 0.11 | 0.89 (0.77–1.03) |
Degree of polypharmacy | ||||
0 | Reference | |||
1–2 | 0.21 (0.27) | 0.81 | 0.42 | 1.24 (0.74–2.09) |
3–5 | 0.40 (0.31) | 1.29 | 0.20 | 1.50 (0.81–2.77) |
Insurance status | ||||
Full member | 0.14 (0.34) | 0.42 | 0.67 | 0.16 (0.59–2.26) |
Pensioner | 0.14 (0.41) | 0.33 | 0.74 | 1.15 (0.51–2.57) |
Unknown | – | – | – | – |
Family-insured | Reference | |||
Corticosteroid prescription | ||||
No | Reference | |||
Yes | 0.22 (0.17) | 1.29 | 0.20 | 1.25 (0.89–1.76) |
Psoriasis diagnosis in the same quarter as the index event | ||||
No | Reference | |||
Yes | 0.19 (0.22) | 0.86 | 0.39 | 1.21 (0.78–1.88) |
CCI Charlson Comorbidity Index, CI confidence interval, SE standard error